Biology of AMPA receptor interacting proteins - From biogenesis to synaptic plasticity

Neuropharmacology. 2021 Oct 1:197:108709. doi: 10.1016/j.neuropharm.2021.108709. Epub 2021 Jul 13.

Abstract

AMPA-type glutamate receptors mediate the majority of excitatory synaptic transmission in the central nervous system. Their signaling properties and abundance at synapses are both crucial determinants of synapse efficacy and plasticity, and are therefore under sophisticated control. Unique to this ionotropic glutamate receptor (iGluR) is the abundance of interacting proteins that contribute to its complex regulation. These include transient interactions with the receptor cytoplasmic tail as well as the N-terminal domain locating to the synaptic cleft, both of which are involved in AMPAR trafficking and receptor stabilization at the synapse. Moreover, an array of transmembrane proteins operate as auxiliary subunits that in addition to receptor trafficking and stabilization also substantially impact AMPAR gating and pharmacology. Here, we provide an overview of the catalogue of AMPAR interacting proteins, and how they contribute to the complex biology of this central glutamate receptor. This article is part of the special Issue on 'Glutamate Receptors - AMPA receptors'.

Keywords: AMPA receptor; AMPAR gating; AMPAR trafficking; Auxiliary subunit; PDZ domain.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics*
  • Nerve Tissue Proteins / physiology*
  • Neuronal Plasticity / physiology*
  • Receptors, AMPA / biosynthesis
  • Receptors, AMPA / genetics*
  • Receptors, AMPA / physiology*
  • Synapses / metabolism
  • Synapses / physiology*

Substances

  • Nerve Tissue Proteins
  • Receptors, AMPA